Utility of circulating tumor DNA in monitoring treatment response to immune checkpoint inhibitors in patients with advanced genitourinary cancers.

被引：0
作者：
Jang, Albert
Jaeger, Ellen B.
Rauterkus, Grant
Lieberman, Alexandra
Huang, Minqi
Lanka, Sree M.
Sudhaman, Sumedha
Mahmood, Tamara
Pajak, Natalia
Calhoun, Mark
Tlemcani, Kaoutar
ElNaggar, Adam
Liu, Minetta
Lewis, Brian E.
Layton, Jodi Lyn
Sartor, A. Oliver
Barata, Pedro C.
机构：
[1] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[2] Tulane Univ, New Orleans, LA 70118 USA
[3] Tulane Canc Ctr, New Orleans, LA USA
[4] Natera Inc, Austin, TX USA
[5] Natera Inc, San Carlos, CA USA
[6] Univ Hosp Seidman Canc Ctr, Dept Internal Med, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
721
引用
收藏
页数：1
相关论文
共 50 条
[21]   Potentially targetable alterations identified in circulating tumor DNA (ctDNA) from patients (pts) with advanced rare cancers. [J].
Okuma, Hitomi Sumiyoshi ;
Yonemori, Kan ;
Kojima, Yuki ;
Tanioka, Maki ;
Sudo, Kazuki ;
Noguchi, Emi ;
Hijioka, Susumu ;
Wakakuwa, Keiko ;
Kato, Ken ;
Ichikawa, Hitoshi ;
Hirakawa, Akihiro ;
Kuchiba, Aya ;
Shibata, Taro ;
Sukigara, Tamie ;
Nakamura, Kenichi ;
Yamamoto, Noboru .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[22]   Exploratory analysis of predictive biomarkers for immune-related adverse events (irAEs) due to checkpoint inhibitors (CPIs) in patients with genitourinary (GU) cancers. [J].
Vosoughi, Elham ;
Kaakour, Dalia ;
Chen, Wen-Pin ;
Mar, Nataliya .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[23]   Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC [J].
Dall'Olio, F. G. ;
Parisi, C. ;
Marcolin, L. ;
Brocchi, S. ;
Caramella, C. ;
Conci, N. ;
Carpani, G. ;
Gelsomino, F. ;
Ardizzoni, S. ;
Marchese, P. V. ;
Paccapelo, A. ;
Grilli, G. ;
Golfieri, R. ;
Besse, B. ;
Ardizzoni, A. .
ANNALS OF ONCOLOGY, 2021, 32 :S1028-S1028
[24]   Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC [J].
Dall'Olio, Filippo G. ;
Parisi, Claudia ;
Marcolin, Laura ;
Brocchi, Stefano ;
Caramella, Caroline ;
Conci, Nicole ;
Carpani, Giulia ;
Gelsomino, Francesco ;
Ardizzoni, Stefano ;
Marchese, Paola Valeria ;
Paccapelo, Alexandro ;
Grilli, Giada ;
Golfieri, Rita ;
Besse, Benjamin ;
Ardizzoni, Andrea .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[25]   Tumor antigenic peptide vaccine enhances anti-tumor effects of Immune checkpoint inhibitors against refractory cancers. [J].
Ueda, Shohei ;
Irie, Atsushi ;
Senju, Satoru ;
Ito, Koyu ;
Hamana, Hiroshi ;
Ogasawara, Koetsu ;
Kishi, Hiroyuki ;
Eto, Masatoshi ;
Nishimura, Yasuharu .
CANCER SCIENCE, 2021, 112 :405-405
[26]   Tumor associated antigen vaccine enhances anti-tumor effects of immune checkpoint inhibitors against refractory cancers. [J].
Ueda, Shohei ;
Ushijima, Miho ;
Irie, Atsushi ;
Senju, Satoru ;
Ito, Koyu ;
Hamana, Hiroshi ;
Kishi, Hiroyuki ;
Ogasawara, Koetsu ;
Udaka, Keiko ;
Eto, Masatoshi ;
Nishimura, Yasuharu .
CANCER SCIENCE, 2023, 114 :282-282
[27]   Circulating tumor DNA strongly predicts efficacy of chemotherapy plus immune checkpoint inhibitors in patients with advanced gastro-esophageal adenocarcinoma [J].
Tougeron, David ;
Louvet, Christophe ;
Desrame, Jerome ;
Evesque, Ludovic ;
Angelergues, Antoine ;
Carnot, Aurelien ;
Breysacher, Gilles ;
Zaanan, Aziz ;
Etchepare, Nicolas ;
Mabro, May ;
Kaluzinski, Laure ;
Petorin, Caroline ;
Chibaudel, Benoist ;
Aparicio, Thomas ;
Bodere, Anais ;
Rinaldi, Yves ;
Le Malicot, Karine ;
Emile, Jean-Francois ;
Lepage, Come ;
Baures, Aurelia ;
Djamai, Hanane ;
Taly, Valerie ;
Laurent-Puig, Pierre .
COMMUNICATIONS MEDICINE, 2025, 5 (01)
[28]   The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors [J].
Jin, Ying ;
Chen, Dong-Liang ;
Wang, Feng ;
Yang, Chao-pin ;
Chen, Xu-Xian ;
You, Jin-qi ;
Huang, Jin-Sheng ;
Shao, Yang ;
Zhu, Dong-Qin ;
Ouyang, Yu-Ming ;
Luo, Hui-Yan ;
Wang, Zhi-Qiang ;
Wang, Feng-Hua ;
Li, Yu-Hong ;
Xu, Rui-Hua ;
Zhang, Dong-Sheng .
MOLECULAR CANCER, 2020, 19 (01)
[29]   The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors [J].
Ying Jin ;
Dong-Liang Chen ;
Feng Wang ;
Chao-pin Yang ;
Xu-Xian Chen ;
Jin-qi You ;
Jin-Sheng Huang ;
Yang Shao ;
Dong-Qin Zhu ;
Yu-Ming Ouyang ;
Hui-Yan Luo ;
Zhi-Qiang Wang ;
Feng-Hua Wang ;
Yu-Hong Li ;
Rui-Hua Xu ;
Dong-Sheng Zhang .
Molecular Cancer, 19
[30]   CLINICAL UTILITY OF THE QUANTITATIVE MONITORING OF CIRCULATING TUMOR DNA IN PATIENTS WITH ADVANCED PDAC UNDERGOING CHEMOTHERAPY [J].
Sugimori, Makoto ;
Sugimori, Kazuya ;
Jimbo, Chiaya ;
Tsuyuki, Sho ;
Kaneta, Yoshihiro ;
Hirotani, Akane ;
Sanga, Katsuyuki ;
Komiyama, Satoshi ;
Sato, Takeshi ;
Tezuka, Shun ;
Goda, Yoshihiro ;
Irie, Kuniyasu ;
Miwa, Haruo ;
Miura, Yuuki ;
Ishii, Tomohiro ;
Shibata, Wataru ;
Nozaki, Akito ;
Maeda, Shin .
GASTROENTEROLOGY, 2019, 156 (06) :S498-S498
12345